As one of the most important and famous applications of blockchain technology, cryptocurrency has attracted extensive attention recently. Empowered by blockchain technology, all the transaction ...records of cryptocurrencies are irreversible and recorded in blocks. These transaction records containing rich information and complete traces of financial activities are publicly accessible, thus providing researchers with unprecedented opportunities for data mining and knowledge discovery in this area. Networks are a general language for describing interacting systems in the real world, and a considerable part of existing work on cryptocurrency transactions is studied from a network perspective. This survey aims to analyze and summarize the existing literature on analyzing and understanding cryptocurrency transactions from a network perspective. Aiming to provide a systematic guideline for researchers and engineers, we present the background information of cryptocurrency transaction network analysis and review existing research in terms of three aspects, i.e., network modeling, network profiling, and network-based detection. For each aspect, we introduce the research issues, summarize the methods, and discuss the results and findings given in the literature. Furthermore, we present the main challenges and several future directions in this area.
In this paper, we propose a secure and efficient blockchain-based data trading approach for the Internet of Vehicles (IoV). First, we apply consortium blockchain technologies to ensure secure and ...truthful data trading, and propose a general blockchain-based data trading framework for IoV. Second, to improve the efficiency of data trading and encourage more participants to trade data, we propose an iterative double auction mechanism with the purpose of achieving social welfare maximization, in which pricing rules of buyers and sellers are designed to induce participants to submit bids and to decide the amount of traded data and its price among buyers and sellers. In particular, in our algorithm, the hidden information of individuals can be extracted gradually so that the privacy of participants in data trading can be protected well. Finally, the experimental results show the efficiency of our proposed algorithm. Moreover, the correctness of social welfare maximization, incentive compatibility, individually rationality, and weakly budget balance of our auction mechanism are verified in the experiments.
The spike protein of SARS-CoV-2 has been undergoing mutations and is highly glycosylated. It is critically important to investigate the biological significance of these mutations. Here, we ...investigated 80 variants and 26 glycosylation site modifications for the infectivity and reactivity to a panel of neutralizing antibodies and sera from convalescent patients. D614G, along with several variants containing both D614G and another amino acid change, were significantly more infectious. Most variants with amino acid change at receptor binding domain were less infectious, but variants including A475V, L452R, V483A, and F490L became resistant to some neutralizing antibodies. Moreover, the majority of glycosylation deletions were less infectious, whereas deletion of both N331 and N343 glycosylation drastically reduced infectivity, revealing the importance of glycosylation for viral infectivity. Interestingly, N234Q was markedly resistant to neutralizing antibodies, whereas N165Q became more sensitive. These findings could be of value in the development of vaccine and therapeutic antibodies.
Display omitted
•Over 100 mutations were selected for analyses on their infectivity and antigenicity•The dominant D614G itself and combined with other mutations are more infectious•Ablation of both N331 and N343 glycosylation at RBD drastically reduced infectivity•Ten mutations such as N234Q, L452R, A475V, and V483A was markedly resistant to some mAbs
Eighty natural variants and 26 glycosylation spike mutants of SARS-CoV-2 were analyzed in terms of infectivity and antigenicity using high throughput pseudovirus assay in conjunction with neutralizing antibodies.
Layered materials have attracted tremendous interest for accessing two-dimensional structures. Materials such as graphite or transition metal dichalcogenides, in which the layers are held together by ...van der Waals interactions, can be exfoliated through a variety of processes in a manner that retains the structure and composition of the monolayers, but this has proven difficult for solids with stronger interlayer interactions. Here, we demonstrate the exfoliation of AgCrS2, a member of the AMX2 family (where A is a monovalent metal, M is a trivalent metal and X is a chalcogen), through intercalation with tetraalkylammonium cations, chosen for their suitable redox potential. The as-exfoliated nanosheets consist of Ag layers sandwiched between two CrS2 layers, similar to their structure in the bulk. They show superionic behaviour at room temperature, with an ionic conductivity of 33.2 mS cm−1 at 298 K that originates from Ag+ ions rapidly hopping between neighbouring tetrahedral interstices; in the bulk, this behaviour is only observed above 673 K.Layered materials held together by weak interactions can be exfoliated into monolayers that retain the structure and composition of their bulk counterpart, but this has remained challenging to achieve for non-van der Waals materials. Now, AgCrS2 has been exfoliated into such CrS2AgCrS2 nanosheets through intercalation with tetraalkylammonium cations chosen for their suitable redox potential. The nanosheets show superionic behaviour at room temperature.
Pseudotyped viruses are useful virological tools because of their safety and versatility. On the basis of a vesicular stomatitis virus (VSV) pseudotyped virus production system, we developed a ...pseudotyped virus-based neutralization assay against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in biosafety level 2 facilities. Compared with the binding antibody test, the neutralization assay could discriminate the protective agents from the antibody family. This protocol includes production and titration of the SARS-CoV-2 S pseudotyped virus and the neutralization assay based on it. Various types of samples targeting virus attachment and entry could be evaluated for their potency, including serum samples derived from animals and humans, monoclonal antibodies and fusion inhibitors (peptides or small molecules). If the pseudotyped virus stock has been prepared in advance, it will take 2 days to get the potency data for the candidate samples. Experience in handling cells is needed before implementing this protocol.
SARS-CoV-2 variants could induce immune escape by mutations on the receptor-binding domain (RBD) and N-terminal domain (NTD). Here we report the humoral immune response to circulating SARS-CoV-2 ...variants, such as 501Y.V2 (B.1.351), of the plasma and neutralizing antibodies (NAbs) elicited by CoronaVac (inactivated vaccine), ZF2001 (RBD-subunit vaccine) and natural infection. Among 86 potent NAbs identified by high-throughput single-cell VDJ sequencing of peripheral blood mononuclear cells from vaccinees and convalescents, near half anti-RBD NAbs showed major neutralization reductions against the K417N/E484K/N501Y mutation combination, with E484K being the dominant cause. VH3-53/VH3-66 recurrent antibodies respond differently to RBD variants, and K417N compromises the majority of neutralizing activity through reduced polar contacts with complementarity determining regions. In contrast, the 242-244 deletion (242-244Δ) would abolish most neutralization activity of anti-NTD NAbs by interrupting the conformation of NTD antigenic supersite, indicating a much less diversity of anti-NTD NAbs than anti-RBD NAbs. Plasma of convalescents and CoronaVac vaccinees displayed comparable neutralization reductions against pseudo- and authentic 501Y.V2 variants, mainly caused by E484K/N501Y and 242-244Δ, with the effects being additive. Importantly, RBD-subunit vaccinees exhibit markedly higher tolerance to 501Y.V2 than convalescents, since the elicited anti-RBD NAbs display a high diversity and are unaffected by NTD mutations. Moreover, an extended gap between the third and second doses of ZF2001 leads to better neutralizing activity and tolerance to 501Y.V2 than the standard three-dose administration. Together, these results suggest that the deployment of RBD-vaccines, through a third-dose boost, may be ideal for combating SARS-CoV-2 variants when necessary, especially for those carrying mutations that disrupt the NTD supersite.
The 501Y.V2 variants of SARS-CoV-2 containing multiple mutations in spike are now dominant in South Africa and are rapidly spreading to other countries. Here, experiments with 18 pseudotyped viruses ...showed that the 501Y.V2 variants do not confer increased infectivity in multiple cell types except for murine ACE2-overexpressing cells, where a substantial increase in infectivity was observed. Notably, the susceptibility of the 501Y.V2 variants to 12 of 17 neutralizing monoclonal antibodies was substantially diminished, and the neutralization ability of the sera from convalescent patients and immunized mice was also reduced for these variants. The neutralization resistance was mainly caused by E484K and N501Y mutations in the receptor-binding domain of spike. The enhanced infectivity in murine ACE2-overexpressing cells suggests the possibility of spillover of the 501Y.V2 variants to mice. Moreover, the neutralization resistance we detected for the 501Y.V2 variants suggests the potential for compromised efficacy of monoclonal antibodies and vaccines.
Display omitted
•501Y.V2 showed no higher infectivity in cells with hACE2 comparing to 614G variant•501Y.V2 showed increased infectivity in cells with mACE2 compared to 614G variant•501Y.V2 escaped neutralization by most of neutralizing monoclonal antibodies•501Y.V2 significantly compromised the inhibitory effects of polyclonal antibodies
Experiments with pseudotyped viruses show that the 501Y.V2 variant of SARS-CoV-2 exhibits resistance to neutralization from monoclonal antibodies and sera from convalescent as well as immunized individuals, predominantly due to the E484K and N501Y mutations in the receptor-binding domain of the viral spike protein.
Pseudoviruses are useful virological tools because of their safety and versatility, especially for emerging and re-emerging viruses. Due to its high pathogenicity and infectivity and the lack of ...effective vaccines and therapeutics, live SARS-CoV-2 has to be handled under biosafety level 3 conditions, which has hindered the development of vaccines and therapeutics. Based on a VSV pseudovirus production system, a pseudovirus-based neutralization assay has been developed for evaluating neutralizing antibodies against SARS-CoV-2 in biosafety level 2 facilities. The key parameters for this assay were optimized, including cell types, cell numbers, virus inoculum. When tested against the SARS-CoV-2 pseudovirus, SARS-CoV-2 convalescent patient sera showed high neutralizing potency, which underscore its potential as therapeutics. The limit of detection for this assay was determined as 22.1 and 43.2 for human and mouse serum samples respectively using a panel of 120 negative samples. The cutoff values were set as 30 and 50 for human and mouse serum samples, respectively. This assay showed relatively low coefficient of variations with 15.9% and 16.2% for the intra- and inter-assay analyses respectively. Taken together, we established a robust pseudovirus-based neutralization assay for SARS-CoV-2 and are glad to share pseudoviruses and related protocols with the developers of vaccines or therapeutics to fight against this lethal virus.
For two-dimensional transition metal dichalcogenides (TMD) materials, achieving large size with high quality to provide a basis for the next generation of electronic device geometries has been a ...long-term need. Here, we demonstrate that, by only manual shaking within several seconds, very large-sized TMD monolayers that cover a wide range of group IVB-VIB transition metal sulfides and selenides can be efficiently harvested from intercalated single-crystal counterparts. Taking TaS2 as examples, monolayers up to unprecedented size (>100 μm) are obtained while maintaining high crystalline quality and the phase structure of the starting materials. Furthermore, benefiting from the gentle manual shaking, we unraveled the atomic-level correlation between the intercalated lattice-strain effects and exfoliated nanosheets, and that strong tensile strain usually led to very large sizes. This work helps to deepen the understanding of exfoliation mechanism and provides a powerful tool for producing large-sized and high-quality TMD nanosheets appealing for further applications.
BRD4 is well known for its role in super-enhancer organization and transcription activation of several prominent oncogenes including
and
As such, BRD4 inhibitors are being pursued as promising ...therapeutics for cancer treatment. However, drug resistance also occurs for BRD4-targeted therapies. Here, we report that BRD4 unexpectedly interacts with the LSD1/NuRD complex and colocalizes with this repressive complex on super-enhancers. Integrative genomic and epigenomic analyses indicate that the BRD4/LSD1/NuRD complex restricts the hyperactivation of a cluster of genes that are functionally linked to drug resistance. Intriguingly, treatment of breast cancer cells with a small-molecule inhibitor of BRD4, JQ1, results in no immediate activation of the drug-resistant genes, but long-time treatment or destabilization of LSD1 by PELI1 decommissions the BRD4/LSD1/NuRD complex, leading to resistance to JQ1 as well as to a broad spectrum of therapeutic compounds. Consistently, PELI1 is up-regulated in breast carcinomas, its level is negatively correlated with that of LSD1, and the expression level of the BRD4/LSD1/NuRD complex-restricted genes is strongly correlated with a worse overall survival of breast cancer patients. Together, our study uncovers a functional duality of BRD4 in super-enhancer organization of transcription activation and repression linking to oncogenesis and chemoresistance, respectively, supporting the pursuit of a combined targeting of BRD4 and PELI1 in effective treatment of breast cancer.
PDF
